trending Market Intelligence /marketintelligence/en/news-insights/trending/v2eizdcy0iznttbocmnhnw2 content esgSubNav
In This List

Cellnovo shareholders elect director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cellnovo shareholders elect director

Cellnovo Ltd. shareholders elected Pierre Chancel to the U.K.-based medical technology company's board.

Chancel has more than 30 years of experience in the pharmaceutical and medical device sectors. He most recently worked at Sanofi as senior vice president of the global diabetes division, where he oversaw strategy, research and development, and marketing and commercial activities, Cellnovo said in a statement.

Chancel will help the company as it focuses on boosting sales of its diabetes management system.